Moreover, CD79A exhibited a strong correlation with several immune cells, immunoinhibitors, and immunostimulators (Supplementary Figure S2B), such as tumor-infiltrating lymphocytes including immature B cells (r = 0.697, p = 2.2–16) and activated B cells (r = 0.848, p = 2.2e–16), immunoinhibitors including BTLA (r = 0.659, p = 2.2–16) and TIGIT (r = 0.614, p = 2.2e–16), and immunostimulators including CD27 (r = 0.907, p = 2.2–16) and TNFRSF17 (r = 0.883, p = 2.2e–16) in the TISIDB database (Supplementary Figure S2C). The gene discussed is BTLA; the disease is neoplasm.